21 :110-112 Key words: diabetes, cardiovascular outcome trial, semaglutide Licensing requirements for new antidiabetic drugs changed in the USA following the rosiglitazone controversy, and between 2008 and 2020 a dedicated randomised controlled cardiovascular outcome trial (CVOT) was usually required either before or after licensing
All outcomes and analyses were prespecified, with the exception of the estimated BV and PV, as well as the regression analyses used to explore potential mechanisms, so these data should be treated as hypothesis-generating
Also, other researchers found similar rates of congenital heart defects and failure to thrive in exposed and non-exposed groups
Why Choose Beck Aesthetic Surgery for Weight Loss Shots
Shelf Life, Storage & Safety Guide Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes mellitus and weight management in adults with obesity or overweight with weight-related comorbidities
Gs program goes above and beyond with: Physician-Guided Treatment You will be kept informed thanks to regular contact with Dr
